Exenatide, diabetes particularly effective new tool

A new glucose-lowering drug, made from an endogenous gut hormone, has several advantages over current treatment of patients with type 2 diabetes. This is shown by two PhD projects of the Diabetes Center VU University Medical Center on the effects and underlying mechanisms of the drug exenatide. On September 9 this is in VUmc substantial attention to an international symposium and a double